Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical Prostatectomy
In this 5-year follow-up study from an institution that was an early adopter of PSMA PET/CT, PSMA PET/CT-guided sRT was associated with favorable oncologic outcomes. Exploratory analyses suggest a potential benefit of WPRT following a positive PSMA PET/CT and of ADT in patients with N1/M1 disease.
Authors
- John Paul Shen (ORCID: https://orcid.org/0000-0003-4588-2775)
- John Nikitas (ORCID: https://orcid.org/0000-0002-1101-7233)
- Wesley R. Armstrong (ORCID: https://orcid.org/0000-0002-9168-8511)
- Clayton Smith (ORCID: https://orcid.org/0000-0002-8509-6237)
- R. E. Reiter
- Luca Valle (ORCID: https://orcid.org/0000-0002-5781-4174)
- J.G. Moore
- Matthew B. Rettig (ORCID: https://orcid.org/0000-0002-7394-3056)
- Vishnu Murthy (ORCID: https://orcid.org/0000-0001-7606-1318)
- Michael L. Steinberg (ORCID: https://orcid.org/0000-0002-4292-5824)
- Andrea Farolfi (ORCID: https://orcid.org/0000-0002-5443-4301)
- Jérémie Calais
- Makayla Roberts
- Kevyn J Clark
- Johannes Czernin
- Tristan Grogan
- Nicholas G. Nickols
- Amar U. Kishan
Institutions
- University of California, Los Angeles (US)
- Azienda USL di Bologna (IT)
- VA Greater Los Angeles Healthcare System (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2026-02-01
- DOI
- https://doi.org/10.6004/jnccn.2025.7102
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00